CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases

Kardiologia Polska

Volumn 65, Issue 3, 2007, Pages 237-244

  Rechciński, Tomasz ^a   Grȩbowska, Aneta ^b   Kurpesa, Małgorzata ^a   Peruga, Zbigniew ^a   Dziuba, Michał ^a   Krzemińska Pakuła, Maria ^a   Rudnicka, Wiesława ^b   Chmiela, Magdalena ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

CD14 polymorphism; Myocardial infarction; Screening tests

Indexed keywords

CD14 ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENOTYPE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; POLYMERASE CHAIN REACTION; RISK FACTOR; SMOKING;

EID: 34250786811     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bryła M. Sytuacja epidemiologiczna w zakresie chorób uk?adu kra̧żenia. In: Maniecka-Bryła I, Martini-Fiwek J (eds). Epidemiologia z elementami biostatystyki. Wydawnictwo Uniwersytetu Medycznego w Łodzi, Łódź 2005; 150-82.
2. Chmiela M, Kowalewicz-Kulbat M, Miszczak A, et al. A link between Helicobacter pylori and/or Chlamydia spp. infections and atherosclerosis. FEMS Immunol Med Microbiol 2003; 36: 187-92.
3. Arroyo-Espliguero R, Avanzas P, Jeffery S, et al. CD14 and toll - like receptor 4: a link between infection and acute coronary events? Heart 2004; 90: 983-8.
4. Koenig W, Khuseyinova N, Hoffmann MM, et al. CD14 C(-260)→T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 2002; 40: 34-42.
5. Auer J, Weber T, Berent R, et al. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics 2003; 3: 317-28.
6. Longobardo MT, Cefalu AB, Pezzino F, et al. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin Exp Med 2003; 3: 161-5.
7. Hohda S, Kimura A, Sasaoka T, et al. Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J 2003: 44: 613-22.
8. Arroyo-Espliguero R, El-Sharnouby K, Vazquez-Rey E, et al. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. Int J Cardiol 2005; 98: 307-12.
9. Hubacek JA, Rothe G, Pit'ha J, et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99: 3218-20.
10. Ito D, Murata M, Tanahashi N, et al. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 2000; 31: 2661-4.
11. Eilertsen KE, Olsen JO, Brox J, et al. Association of the -159 C→T polymorphism in the CD14 promoter with variations in serum lipoproteins in healthy subjects. Blood Coagul Fibrinolysis 2003; 14: 663-70.
12. Unkelbach K, Gardemann A, Kostrzewa M, et al. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 1999; 19: 932-8.
13. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
14. Karhukorpi J, Yan Y, Niemela S, et al. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin Exp Immunol 2002; 128: 326-32.
15. Koch W, Kastrati A, Mehilli J, et al. CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. Am Heart J 2002; 143: 971-6.
16. Chmiela M, Grȩbowska A, Rechciński T, et al. Response to LPS and H. pylori disease diversity. Helicobacter 2005; 10, 494, 05.15.
17. Grȩbowska A, Rechciński T, Moran A, et al. Increased levels of immunoglobuline and non-immunoglobuline markers of host response to h. pylori LPS in the patients with coronary artery disease (CAD). Current Trends in Immunology 2006; 7: 85-96.
18. Li Y, Xiong XQ, Zhang PA, et al. Association of C-159-T polymorphism in promoter region of CD14 and coronary heart disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhu 2005; 22: 687-90.
19. Losito A, Kalidas K, Santoni S, et al. Association of the -159C/T polymorphism of the endotoxin receptor (CD14) with carotid artery disease and cardiovascular mortality in dialysis patients. Blood Purif 2005; 23: 128-33.
20. Rupp J, Goepel W, Kramme E, et al. CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes. Genes Immun 2004; 5: 435-8.
21. Grȩbowska A, Rechciński T, Ba̧k-Romaniszyn L, et al. Potential role of LPS in the outcome of Helicobacter pylori related diseases. Pol J Microbiol 2006; 55: 25-30.
22. Rechciński T, Grȩbowska A, Kurpesa M, et al. Occurrence of serum class G immunoglobulins interacting with specific antigens of Helicobacter pylori in patients with unstable coronary artery disease and in symptomless individuals. Pol J Microbiol 2005; 54: 221-5.
23. Druszczyńska M, Strapagiel D, Kwiatkowska S, et al. Tuberculosis bacilli still posing a threat. Polymorphism of genes regulating anti-mycobacterial properties of macrophages. Pol J Microbiol 2006; 55: 7-12.
24. Kandzari DE, Goldschmidt-Clermont PJ. Making positive out of negative trials. Am Heart J 2002; 143: 950-1.